|
|
.
NPI Detail
NPI: 1164493847
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
825 XXXXXXXX XXX X
SEATTLE, WA 981094405
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1164493847*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXXX
|
$XXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1442
|
Inj filgrastim excl biosimil
|
XXXXXX
|
$XXXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXXX
|
$XXXXXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXXXX
|
$XXXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXXX
|
-
|
| J0185
|
Inj., aprepitant, 1 mg
|
XXXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXXX
|
$XXXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXXX
|
-
|
| J0881
|
Darbepoetin alfa, non-esrd
|
XXXXXX
|
$XXXXXX.XX
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXXX
|
$XXXXXX.XX
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXXX
|
$XXXXXXX.XX
|
| J1447
|
Inj tbo filgrastim 1 microg
|
XXXXXX
|
$XXXXX.XX
|
| J1756
|
Iron sucrose injection
|
XXXXXX
|
-
|
| J9025
|
Azacitidine injection
|
XXXXX
|
$XXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXXX.XX
|
| J9047
|
Injection, carfilzomib, 1 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9034
|
Inj., bendeka 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J9177
|
Inj enfort vedo-ejfv 0.25mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9176
|
Injection, elotuzumab, 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J0461
|
Atropine sulfate injection
|
XXXXX
|
-
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J8540
|
Oral dexamethasone
|
XXXXX
|
-
|
| J9305
|
Inj. pemetrexed nos 10mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9035
|
Bevacizumab injection
|
XXXXX
|
$XXXXXXX.XX
|
| J9171
|
Docetaxel injection
|
XXXXX
|
-
|
| J9022
|
Inj, atezolizumab,10 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9041
|
Injection, bortezomib, 0.1mg
|
XXXXX
|
$XXXXXXX.XX
|
| J2469
|
Palonosetron hcl
|
XXXXX
|
-
|
| J2405
|
Ondansetron hcl injection
|
XXXXX
|
-
|
| J1071
|
Inj testosterone cypionate
|
XXXXX
|
-
|
| J0896
|
Inj luspatercept-aamt 0.25mg
|
XXXXX
|
$XXXXXX.XX
|
| J9358
|
Inj fam-trastu deru-nxki 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J9311
|
Inj rituximab, hyaluronidase
|
XXXXX
|
$XXXXXX.XX
|
| J9312
|
Inj., rituximab, 10 mg
|
XXXXX
|
$XXXXXXX.XX
|
| J9349
|
Inj., tafasitamab-cxix
|
XXXXX
|
$XXXXXX.XX
|
| J9355
|
Inj trastuzumab excl biosimi
|
XXXXX
|
$XXXXXXX.XX
|
| J1930
|
Lanreotide injection
|
XXXXX
|
$XXXXXXX.XX
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXXX
|
$XXXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
